Major histocompatibility complex heavy chain accumulation in the endoplasmic reticulum of oligodendrocytes results in myelin abnormalities

Journal of Neuroscience Research

Volumn 59, Issue 2, 2000, Pages 160-169

  Baerwald, Kristine D ^a,b,d   Corbin, Joshua G ^a,b,c   Popko, Brian ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Demyelinating disorders; ER overload; Interferon gamma; MHC class I

Indexed keywords

BETA 2 MICROGLOBULIN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MYELIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; DEMYELINATING DISEASE; EMBRYO; ENDOPLASMIC RETICULUM; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; OLIGODENDROGLIA; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN TRANSPORT; TRANSGENIC MOUSE;

ANIMALS; BIOLOGICAL TRANSPORT; BLOTTING, NORTHERN; CORPUS CALLOSUM; DEMYELINATING DISEASES; ENDOPLASMIC RETICULUM; GENE EXPRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTERFERON TYPE II; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELIN BASIC PROTEINS; MYELIN SHEATH; OLIGODENDROGLIA; PHENOTYPE; RNA, MESSENGER;

EID: 0034651029     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(20000115)59:2<160::AID-JNR2>3.0.CO;2-K     Document Type: Article

References (56)

1. Agresti C, D'Urso D, Levi G. 1996. Reversible inhibitory effects of interferon-gamma and tumour necrosis factor-α on oligodendroglial lineage cell proliferation and differentiation in vitro. Eur J Neurosci 8:1106-1116.
2. Anderson TJ, Schneider A, Barrie JA, Klugmann M, McCulloch MC, Kirkham D, Kyriakides E, Nave KA, Griffiths IR. 1998. Late-onset neurodegeneration in mice with increased dosage of the proteolipid protein gene. J Comp Neurol 394:506-519.
3. Baerwald KD, Popko B. 1998. Developing and mature oligodendrocytes respond differently to the immune cytokine interferon-gamma. J Neurosci Res 52:230-239.
4. Benjamins JA, Nedelkoska L. 1996. Release of intracellular calcium stores leads to retraction of membrane sheets and cell death in mature mouse oligodendrocytes. Neurochem Res 21:471-479.
5. Calder VL, Wolswijk G, Noble M. 1988. The differentiation of O-2A progenitor cells into oligodendrocytes is associated with a loss of inducibility of Ia antigens. Eur J Immunol 18:1195-1201.
6. Corbin JG, Kelly D, Rath EM, Baerwald KD, Suzuki K, Popko B. 1996. Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol Cell Neurosci 7:354-370.
7. Drew PD, Lonergan M, Goldstein ME, Lampson LA, Ozato K, McFarlin DE. 1993. Regulation of MHC class 1 and beta 2-microglobulin gene expression in human neuronal cells. Factor binding to conserved cis-acting regulatory sequences correlates with expression of the genes. J Immunol 150:3300-3310.
8. D'Urso D, Prior R, Greiner-Petter R, Gabreëls-Festen AAWM, Müller HW. 1998. Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP-22. J Neurosci 18:731-740.
9. Gow A, Lazzarini RA. 1996. A cellular mechanism governing the severity of Pelizaeus-Marzbacher disease. Nature Genet 13:422-428.
10. Gow A, Friedrich Jr VL, Lazzarini RA. 1994. Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport. J Neurosci Res 37:574-583.
11. Gow A, Southwood CM, Lazzarini RA. 1998. Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in animal model of Pelizaeus-Merzbacher disease. J Cell Biol 140:925-934.
12. Griffiths I, Klugmann M, Anderson T, Thomson C, Vouyiouklis D, Nave KA. 1998. Current concepts of PLP and its role in the nervous system. Microsc Res Tech 41:344-358.
13. Hasenkrug KJ, Cory JM, Stimfling JH. 1987. Monoclonal antibodies defining mouse tissue antigens encoded by the H-2 region. Immunogenetics 25:136-139.
14. Horwitz MS, Evans CF, McGavern DB, Rodriguez M, Oldstone MBA. 1997. Primary demyelination in transgenic mice expressing interferon-gamma. Nature Med 3:1037-1041.
15. Hsu VW, Yuan LC, Nuchtern JG, Lippincott-Schwartz J, Hammerling GJ, Klausner RD. 1991. A recycling pathway between the endoplasmic reticulum and the Golgi apparatus for retention of unassembled MHC class I molecules. Nature 352:441-444.
16. Huxley C, Passage E, Manson A, Putzu G, Figarella-Branger D, Pellissier JF, Fontes M. 1996. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum Mol Genet 5:563-569.
17. Huxley C, Passage E, Robertson AM, Youl B, Huston S, Manson A, Saberan-Djoniedi D, Figarella-Branger D, Pellissier JF, Thomas PK, Fontes M. 1998. Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum Mol Genet 7:449-458.
18. Inoue Y, Kagawa T, Matsumura Y, Ikenaka K, Mikoshiba K. 1996. Cell death of oligodendrocytes or demyelination induced by overexpression of proteolipid protein depending on expressed gene dosage. Neurosci Res 25:161-172.
19. Kagawa T, Ikenaka K, Inoue Y, Kuriyama S, Tsujii T, Nakao J, Nakajima K, Aruga J, Okano H, Mikoshiba K. 1994. Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron 13:427-442.
20. Kahn-Perles B, Salamero J, Jouans O. 1994. Biogenesis of MHC class I molecules: involvement of multiple chaperone molecules. Eur J Cell Biol 64:176-185.
21. 2M, MHC class I proteins, and CD8+ T cells. Science 248:1227-1230.
22. Li Y, Atashi J, Hayes C, Reap E, Hunt III D, Popko B. 1995. Morphological and molecular response of the MOCH-1 oligodendrocyte cell line to serum and interferon-γ: possible implications for demyelinating disorders. J Neurosci Res 40:189-198.
23. Magyar JP, Martini R, Ruelicke T, Aguzzi A, Adikofer K, Dembic Z, Zielasek J, Toyka KV, Suter U. 1996. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J Neurosci 16:5351-5360.
24. Massa PT, Ozato K, McFarlin DE. 1993. Cell type-specific regulation of major histocompatibility complex (MHC) class I gene expression in astrocytes, oligodendrocytes, and neurons. Glia 8:201-207.
25. Mastronardi FG, Ackerley CA, Arsenault L, Roots BI, Moscarello MA. 1993. Demyelination in a transgenic mouse: a model for multiple sclerosis. J Neurosci Res 36:315-324.
26. McCarthy KD, de Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
27. Milgram SL, Kho ST, Martin GV, Mains RE, Eipper BA. 1997. Localization of integral membrane peptidylglycine α-amidating monooxygenase in neuroendocrine cells. J Cell Sci 110:695-706.
28. Nößner E, Parham P. 1995. Species-specific differences in chaperone interaction of human and mouse major histocompatibility complex class I molecules. J Exp Med 181:327-337.
29. Notterpek L, Shooter EM, Snipes GJ. 1997. Upregulation of the endosomal-lysosomal pathway in the trembler-J neuropathy. J Neurosci 17:4190-4200.
30. Pahl HL, Baeuerle PA. 1997. The ER-overload response: Activation of NF-κB. Trends Biochem Sci 22:63-67.
31. Panitch HS. 1992. Interferons in multiple sclerosis. Drugs 44:946-962.
32. Panitch HS, Hirsch RL, Schindler J, Johnson KP. 1987. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 37:1097-1102.
33. Popko B, Baerwald K. 1999. Oligodendroglial response to the immune cytokine interferon gamma. Neurochem Res 24:331-338.
34. Popko B, Corbin JG, Baerwald KD, Dupree J, Garcia AM. 1997. The effects of interferon-γ on the central nervous system. Mol Neurobiol 14:19-35.
35. Power C, Kong P-A, Trapp BD. 1996. Major histocompatibility complex class I expression in oligodendrocytes induces hypomyelination in transgenic mice. J Neurosci Res 44:165-173.
36. Rajagopalan S, Brenner MB. 1994. Calnexin retains unassembled major histocompatibility complex class I free heavy chains in the endoplasmic reticulum. J Exp Med 180:407-412.
37. Raposo G, van Santen HM, Leijendekker R, Geuze HJ, Ploegh HL. 1995. Misfolded major histocompatibility complex class I molecules accumulate in an expanded ER-Golgi intermediate compartment. J Cell Biol 131: 1403-1419.
38. Readhead C, Schneider A, Griffiths I, Nave K-A. 1994. Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron 12:583-595.
39. Rodriguez M, Miller DJ. 1994. Immune promotion of central nervous system remyelination. Prog Brain Res 103:343-355.
40. Rodriguez M, Scheithauer BW, Forbes G, Kelly PJ. 1993. Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clinic Proc 68:627-636.
41. Roussel G, Neskovic NM, Trifilieff E, Artault J, Nussbaum J. 1987. Arrest of proteolipid transport through the Golgi apparatus in jimpy brain. J Neurocytol 16:195-204.
42. Satoh J, Kim SU, Kastrukoff LF, Takei F. 1991. Expression and induction of intercellular adhesion molecules (ICAMs) and major histocompatibility complex (MHC) antigens on cultured murine oligodendrocytes and astrocytes. J Neurosci Res 29:1-12.
43. Sege K, Rask L, Peterson PA. 1981. Role of β2-microglobulin in the intracellular processing of HLA antigens. Biochemistry 20:4523-4530.
44. Sereda M, Griffiths I, Pühlhofer A, Stewart H, Rossner MJ, Zimmermann F, Magyar JP, Schneider A, Hund E, Meinck H-M, Suter U, Nave K-A. 1996. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 16:1049-1060.
45. Somlyo AP, Somlyo AV. 1986. Electron probe analysis of calcium content and movements in sarcoplasmic reticulum, endoplasmic reticulum, mitochondria, and cytoplasm. J Cardiovasc Pharmacol 8:S42-S47.
46. Suzumura A, Silberberg DH, Lisak RP. 1986. The expression of MHC antigens on oligodendrocytes: induction of polymorphic H-2 expression by lymphokines. J Neuroimmunol 11:179-190.
47. Tosic M, Gow A, Dolivo M, Domanska-Janik K, Lazzarini RA, Matthieu J-M. 1996. Proteolipid/DM-20 proteins bearing the paralytic tremor mutation in peripheral nerves and transfected Cos-7 cells. Neurochem Res 21:423-430.
48. Turnley AM, Morahan G. 1995. Dysmyelination in class I MHC transgenic mice. Microsc Res Tech 32:286-294.
49. Turnley AM, Miller JFAP, Bartlett PF. 1991a. Regulation of MHC molecules on MBP positive oligodendrocytes in mice by IFN-γ and TNF-α. Neurosci Lett 123:45-48.
50. Turnley AM, Morahan G, Okano H, Bernard O, Mikoshiba K, Allison J, Bartlett PF, Miller JFAP. 1991b. Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature (Lond) 353:566-568.
51. Vartanian T, Li Y, Zhao M, Stefansson K. 1995. Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol Med 1:732-743.
52. Vitiello A, Potter TA, Sherman LA. 1990. The role of β2-microglobulin in peptide binding by class I molecules. Science 250:1423-1426.
53. Waxman SG, Sims TJ. 1984. Specificity in central myelination: evidence for local regulation of myelin thickness. Brain Res 292:179-185.
54. Williams DB, Barber BH, Flavell RA, Allen H. 1989. Role of β2-microglobulin in the intracellular transport and surface expression of murine class I histocompatibility molecules. J Immunol 142:2796-2806.
55. Wong GHW, Bartlett PF, Clark-Lewis I, Battye F, Schrader JW. 1984. Inducible expression ot H-2 and Ia antigens on brain cells. Nature 310:688-691.
56. Yoshioka T, Feigenbaum L, Jay G. 1991. Transgenic mouse model for central nervous system demyelination. Mol Cell Biol 11:5479-5486.